文献速递乳腺MR

MRI上距原发乳腺癌超过2cm的乳腺X线摄影隐匿的额外肿瘤是否具有临床意义?

Are Mammographically Occult Additional Tumors Identified More Than 2 Cm Away From the Primary Breast Cancer on MRI Clinically Significant?
PubMed 文献 · Acad Radiol · 2018-06-09

回顾性分析667例乳腺癌患者术前MRI,129例发现150个距原发灶边缘超过2cm的乳腺X线摄影隐匿的同侧额外肿瘤;其中7.0%患者额外肿瘤为未预料浸润性癌或更高分级,额外肿瘤更常见为非肿块型(37.3% vs 24%)和焦点型(10% vs 0.08%)。

要点

  • 术前MRI可检出距原发灶超过2cm的乳腺X线摄影隐匿额外肿瘤,7.0%患者因此发现未预料浸润性癌或更高分级。
  • 额外肿瘤中20.2%直径≥1cm,15.5%的患者额外肿瘤大于原发灶。
  • 额外肿瘤较原发灶更常见为非肿块型(37.3% vs 24%)和焦点型(10% vs 0.08%)。

核心结论

  • MRI上距原发乳腺肿瘤超过2cm的乳腺X线摄影隐匿额外肿瘤若未诊断则不太可能被手术治疗,且可能具有临床意义。

关键影像表现/征象

  • 129例患者共有150个距原发肿瘤边缘超过2cm的同侧乳腺X线摄影隐匿额外肿瘤。
  • 112/129(86.8%)患者有1个额外肿瘤,17/129(13.2%)有2个或以上额外肿瘤。
  • 71/129(55.0%)额外肿瘤位于不同象限,58/129(45.0%)位于同一象限但距离≥2cm。
  • 额外肿瘤较原发肿瘤更常见为非肿块型(37.3% vs 24%,p=0.02)和焦点型(10% vs 0.08%,p<0.001)。

诊断标准与关键数值

  • 额外肿瘤定义为乳腺X线摄影隐匿、经活检证实、距原发肿瘤边缘超过2cm的乳腺肿瘤。
  • 原发肿瘤大小平均1.87±1.25 cm,额外肿瘤平均0.79±0.61 cm(p<0.001)。
  • 20/129(15.5%)患者额外肿瘤大于原发肿瘤,26/129(20.2%)患者额外肿瘤≥1cm。
  • 原发肿瘤浸润性比例81.4%(105/129),额外肿瘤70%(105/150),p=0.03。
  • 9/129(7.0%)患者额外肿瘤为未预料浸润性癌或更高肿瘤分级。

临床应用与阅片要点

  • 术前乳腺MRI可检出距原发灶超过2cm的乳腺X线摄影隐匿额外肿瘤,其中部分为未预料浸润性癌或更高分级,可能影响手术方案。
  • 额外肿瘤中非肿块型和焦点型较原发肿瘤更常见,阅片时需注意此类表现。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: To evaluate the clinical significance of mammographically occult additional tumors identified more than 2cm away from the primary breast cancer on preoperative magnetic resonance imaging (MRI).

MATERIALS AND METHODS: An Institutional Review Board approved review of consecutive preoperative breast MRIs performed from 1/1/08 to 12/31/14, yielded 667 patients with breast cancer. These patients underwent further assessment to identify biopsy proven mammographically occult breast tumors located more than 2cm away from the edge of the primary tumor. Additional MRI characteristics of the primary and secondary tumors and pathology were reviewed. Statistical analysis was performed using SPSS (v. 24).

RESULTS: Of 667 patients with breast cancer, 129 patients had 150 additional ipsilateral mammographically occult tumors that were more than 2cm away from the edge of the primary tumor. One hundred twelve of 129 (86.8%) patients had one additional tumor and 17/129 (13.2%) had two or more additional tumors. In 71/129 (55.0%), additional tumors were located in a different quadrant and in 58/129 (45.0%) additional tumors were in the same quadrant but ≥2cm away. Overall, primary tumor size was significantly larger (mean 1.87± 1.25 cm) than the additional tumors (mean 0.79 ± 0.61cm, p < 0.001). However, in 20/129 (15.5%) the additional tumor was larger and in 26/129 (20.2%) the additional tumor was ≥1cm. The primary tumor was significantly more likely to be invasive (81.4%, 105/129) compared to additional tumors (70%, 105/150, p = 0.03). In 9/129 (7.0%) patients, additional tumors yielded unsuspected invasive cancer orhigher tumor grade. The additional tumor was more likely to be nonmass lesion type (37.3% vs 24% p = 0.02) and focus lesion type (10% vs 0.08%, p < 0.001) compared to primary tumor.

CONCLUSION: Mammographically occult additional tumors identified more than 2cm away from the primary breast tumor on MRI are unlikely to be surgically treated if undiagnosed and may be clinically significant.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Goodman S, Mango V, Friedlander L, et al. Are Mammographically Occult Additional Tumors Identified More Than 2 Cm Away From the Primary Breast Cancer on MRI Clinically Significant? Acad Radiol. 2018. PMID: 29891105. doi:10.1016/j.acra.2018.05.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。